David Yunzhi LI,Jiabing WANG,Zhenfan YANG,Qingbei ZENG,Xiaolin ZHANG
申请号：
US15162816
公开号：
US20160340342A1
申请日:
2016.05.24
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention relates to compounds of formula (I), or a pharmaceutically acceptable salt thereof:which possess inhibitory activity against activating mutant forms of EGFR, and are accordingly useful for their anti-cancer activity and in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of the compounds, or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.
